EPISODE · Apr 9, 2009 · 14 MIN
When Drug Companies Merge & the Effect on Your Practice
Host: Bruce Japsen Guest: John Kreger News of mega-mergers involving the likes of Pfizer and Wyeth or Merck and Schering Plough have turned the pharmaceutical industry on its ear. But what does this mean for you and your patients? John Kreger, a principal with the health care investment bank William Blair & Company, tells the Chicago Tribune's Bruce Japsen about how consolidation among drug companies could impact doctors and their patients.
Embed this episode
NOW PLAYING
When Drug Companies Merge & the Effect on Your Practice
0:00
14:59
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Clinician's Roundtable?
This episode is 14 minutes long.
When was this Clinician's Roundtable episode published?
This episode was published on April 9, 2009.
Can I download this Clinician's Roundtable episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!